Acute high-output heart failure with pulmonary hypertension and severe liver injury caused by amlodipine poisoning: a case report - Wang C, Zhu Q, Tan D, Walline J, Wang Y.
We report a 52-year-old woman who suffered from severe shock after an overdose of amlodipine. Hemodynamic monitoring showed tha... (Source: SafetyLit)
Source: SafetyLit - March 28, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Doctor Gets First U.S. Lung-Liver Transplant for Advanced Lung Cancer
THURSDAY, March 28, 2024 -- Dr. Gary Gibbon didn’t have long to live.
A harsh cocktail of chemotherapy, radiation and immunotherapy for his advanced lung cancer had permanently destroyed his lungs and caused irreparable damage to his... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 28, 2024 Category: General Medicine Source Type: news
AI's Speedy Kidney Discovery; AI Listens in Clinic; Generative AI Nurses
(MedPage Today) -- Welcome to MedAI Roundup, highlighting the latest news and research in healthcare-related artificial intelligence each month.
Researchers have launched an initiative to ensure the safe and ethical use of AI in protein design... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 28, 2024 Category: American Health Source Type: news
Woman, 26, suffers organ failure from HAIR CREAM which caused her kidney to shut down
The woman, from Tunisia, also felt nauseous and suffered from vomiting, diarrhea, fever and back pain just after using treatments with glyoxylic acid. (Source: the Mail online | Health)
Source: the Mail online | Health - March 28, 2024 Category: Consumer Health News Source Type: news
Once-Rejected Drug Now FDA Approved for CKD-Related Anemia
(MedPage Today) -- The FDA approved vadadustat (Vafseo) for chronic kidney disease (CKD)-related anemia in adults who have been on dialysis for at least 3 months, developer Akebia Therapeutics announced on Wednesday.
"Patients receiving maintenance... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 28, 2024 Category: Hematology Source Type: news
Aspirin Shows Promise In Treating Common Liver Disease
Daily low dose aspirin may be an effective treatment for a common type of liver disease, according to a new study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 28, 2024 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Study Reveals Glucagon Receptors' Role in Renal Health Study Reveals Glucagon Receptors' Role in Renal Health
In findings with implications for future therapies in chronic kidney disease, mouse studies show a protective effect of glucagon receptor signaling in the kidney.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 28, 2024 Category: Consumer Health News Tags: Nephrology Source Type: news
Two years after initial rejection, Akebia ’s anemia drug finally gets FDA approval
The FDA approved the Cambridge biotech's drug vadadustat for the treatment of anemia due to chronic kidney disease in adults who have been receiving dialysis for at least three months. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 28, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news
Promising First-In-Human Phase 1B Clinical Study Data from VRON-0200, a Novel, First-in-Class Checkpoint Modifier Immunotherapy for Chronic Hepatitis B Virus Functional Cure, Presented as Late-Breaker at 2024 APASL Global Liver Meeting
Highlights from the Data Presentation Initial safety data presented on the first 10 chronically HBV-infected patients representing 674 patient days of treatment VRON-0200 was well tolerated, with no serious adverse events (SAEs) observed: no patients discontinued treatment one treatment... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 28, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
InnovationRx: Base Editing Pioneer Nicole Gaudelli Joins GV
Plus: eGenesis, the startup behind the first pig-human kidney transplant, is targeting hearts and livers next. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 27, 2024 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick Newsletter No Paywall no-paywall premium Source Type: news
FDA Approves Vafseo (vadadustat) for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
CAMBRIDGE, Mass., March 27, 2024 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 27, 2024 Category: Drugs & Pharmacology Source Type: news
Sotatercept's FDA Approval a New Chapter for Pulmonary Arterial Hypertension
(MedPage Today) -- The FDA approved sotatercept (Winrevair) for treating pulmonary arterial hypertension (PAH) in adults, Merck announced on Tuesday.
A novel activin signaling inhibitor, sotatercept is indicated to increase exercise capacity... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - March 27, 2024 Category: Urology & Nephrology Source Type: news
Simple Risk Score Predicts Severe Cisplatin-Linked Acute Kidney Injury
WEDNESDAY, March 27, 2024 -- A simple risk score consisting of nine covariates predicts the risk for severe cisplatin-associated acute kidney injury (CP-AKI), according to a study published online March 27 in The BMJ.
Shruti Gupta, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 27, 2024 Category: Pharmaceuticals Source Type: news
Japanese Supplement Pill Recalled After Two Deaths and More Than 100 People Hospitalized
TOKYO — Health supplement products believed to have caused two deaths and sickened more than 100 people have been ordered to be taken off store shelves in Japan.
The products from Kobayashi Pharmaceutical Co., billed as helping to lower cholesterol, contained an ingredient called “benikoji,” a red species of mold.
[time-brightcove not-tgx=”true”]
In addition to the products from Osaka-based Kobayashi, more than 40 products from other companies containing benikoji, including miso paste, crackers and a vinegar dressing, were recalled, starting last week, a government health ministry offic...
Source: TIME: Health - March 27, 2024 Category: Consumer Health News Authors: YURI KAGEYAMA / AP Tags: Uncategorized News Desk wire Source Type: news
Could Deep Frying Foods Harm the Brain? Rat Study Suggests It Might
WEDNESDAY, March 27, 2024 -- Fried foods not only wreck the waistline, but they could also be harming the brain, a new study of lab rats suggests.
Fed chow that was fried in sesame or sunflower oil, the rodents developed liver and colon problems... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 27, 2024 Category: General Medicine Source Type: news
